Global Biodefense Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Biodefense refers to the application of medical measures to protect the people from bioterrorism, including interventions such as drugs and vaccinations. Bioterrorism is the intentional release of harmful biological agents for the destruction of mankind. The collaboration of government agencies with pharmaceutical and biotechnology companies for the development of biodefense products to counter the threat of bioterrorism is the major factor boosting the market growth of the biodefense market. There is a rising awareness regarding synthetic biology for the usage of biological organisms to minimise the burden of diseases and for improving agricultural yields. The global biodefense contract development and manufacturing market are projected to reach USD 21.0 billion by 2030 from USD 12.9 billion in 2020, at an approximate CAGR of 4.4%.
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020109
Market Dynamics and Factors:
Presence of favourable government initiatives, increasing investment by the governments in developed and developing countries, and rapid technological advancements in the healthcare sector are the major factors driving the biodefense market across the globe. Annually, the governments are spending heavily on the R&D of vaccines, in order to stay prepared for any bioterrorism attacks. Pharmaceutical companies operating in the biodefense market have huge growth opportunities, because of government’s initiative to be prepared for any kind of bioterrorism. For instance, the Ohio State University has undertaken a progressive research to develop a vaccine against the Zika virus that has proven positive results in the mice models. Furthermore, the rising prevalence of infectious diseases such as Ebola and Covid 19 are likely to provide lucrative opportunities for the biodefense market to grow in the coming future. For instance, as of November 2015, over 28,000 Ebola virus cases and more than 3,800 deaths were reported in Guinea. However, low market penetration of these products in developing and underdeveloped countries may restrain the growth of the biodefense market during the forecast period. Additionally, the presence of the Emergency Usage Authorisation policy is also positively affecting the market growth. The EUA policy enables the FDA Commissioners to authorize the usage of medical products for commercial purposes at the time of a declared emergency in a country posing a threat to public health that are currently unapproved. The government agencies can issue the EUA policy for antiviral drugs to fight against diseases, such as Zika virus infection, SARS, and swine flu.
Market Segmentation :
Global Biodefense Market – By Product Type
Anthrax Vaccine
Small Pox Vaccine
Botulism Vaccine
Radiation Vaccine
Others
Global Biodefense Market – By Application
Military
Civilian
Global Biodefense Market – By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
ROW
Latin America
Middle East
Africa
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @https://www.decisionforesight.com/toc-request/DFS020109
Geographic Analysis:
North America is expected to dominate the global biodefense market in terms of market share during the forecast period. Increase in government funding in order to generate and stockpile sufficient vaccines to be used against anthrax, mainly through various initiatives, such as BioShield Act, Biomedical Advanced Research and Development Authority (BARDA), and the Joint Program Executive Office for Chemical & Biological Defense is the major factor attributing to the market dominance of the region. Biomedical Advanced Research and Development Authority (BARDA), National Institute of Allergy and Infectious Diseases (NIAID), and National Interagency Confederation for Biological Research (NICBR) are the key organizations which provide financial aid for biodefense research and stockpiling in the U.S. Europe is projected to be the fastest-growing market during the forecast period owing to the rising threat of bioterrorism and increasing R&D investments in countries, such as U.K., Germany, and France. Governments in the Asia Pacific region are also investing in R&D for developing and stockpiling vaccines and antitoxins for the biological threats. Japan, China, India, and Australia are the major countries contributing to the biodefense market in the APAC region.
Competitive Scenario:
The key players operating in the global biodefense market are –
Emergent BioSolutions Inc., Bavarian Nordic, Cleveland BioLabs, Altimmune Inc., Siga Technologies Inc., Elusys Therapeutics, Xoma Corporation, Dynport Vaccine Company LLC, Ichor Medical Systems, and Alnylam Pharmaceuticals.
Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020109
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Global Biodefense industry, although key threats, opportunities and disruptive technologies that could shape the Global Biodefense Market supply and demand.
The report tracks the leading market players that will shape and impact the Global Biodefense Market most.
The data analysis present in the Global Biodefense Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Global Biodefense Market business.
The 2021 Annual Global Biodefense Market offers:
100+ charts exploring and analysing the Global Biodefense Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Biodefense Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020109
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionForesi1
https://www.linkedin.com/company/decision-foresight/